Jun 10, 2020 / 07:50PM GMT
Terence Flynn -
Good afternoon, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. This afternoon, we're very pleased to host Bausch Health Companies. Today, joining us from the company, we have Joe Papa, Chairman and CEO; Joe Gordon, who is President and Co-Head of Bausch + Lomb International; Art Shannon, who's Senior Vice President and Head of Investor Relations and Global Communications. Thank you so much all for joining us today, really appreciate the time.
Joe, maybe I'll turn it over to you first to start with some opening remarks before we go through my questions.
Joseph C. Papa - Bausch Health Companies Inc. - Chairman & CEO
Sure. It's a pleasure to have a chance to talk to everybody today. We've been undergoing a transformation of Bausch Health over the past 4 years, and we put together a brand-new team, brand-new leadership team, and we've made great progress. We've now reported 9 consecutive quarters of organic growth. We've got a really strong eye health business with our Bausch + Lomb business, driven by mega trends, which
Bausch Health Companies Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers